Printer Friendly

ALLERCARE ANNOUNCES THIRD QUARTER RESULTS

 BLOOMINGTON, Minn., March 4 /PRNewswire/ -- Allercare, Inc. (OTC Bulletin Board: ALLR), today announced results for the fiscal third quarter ended Jan. 31, 1993.
 Net sales for the quarter ended Jan. 31, 1993, were $231,631 down from $278,764 in the prior year, a decrease of 17 percent. While this year's sales fell short of management's expectations, third quarter sales last year were unusually strong due to the introduction at that time of new packaging for the product line.
 Net sales for the nine months ended Jan. 31, 1993, were $953,379 up from $667,681 in the prior year, an increase of 43 percent. The increase for the first nine months was primarily due to expanded distribution to new accounts and increased volume at current accounts.
 The net loss for the quarter was $177,254, or $0.02 per share versus a net loss last year of $165,027, or $0.02 per share. The net loss for the first nine months was $231,222, or $0.08 per share versus a net income last year of $880,176, or $0.11 per share.
 Last year's results included a $1,265,018 gain from the sale of the Protex line of products. This year's results included a $446,620 charge for debt conversion expense related to the debentures on June 15, 1992. The loss also includes an extraordinary gain of $481,710 from the extinguishment of customer debt.
 Allercare, Inc., a Bloomington-based health and beauty aid products company, markets nail and cuticle treatment products under the brand name LaSalle' "10."
 ALLERCARE, INC.
 Summary of Results
 Fiscal Third Quarter and First Nine Months
 of Fiscal 1993 and 1992
 Quarter Ended Nine Months Ended
 1/31/93 1/31/92 1/31/93 1/31/92
 Net sales $231,631 $278,764 $953,379 $667,681
 Income (loss) before
 extraordinary items (177,254) (165,027) (712,932) 461,768
 Net income (loss) $(177,254) $(165,027) $(231,222) $880,176
 Net income (loss)
 per share before
 extraordinary items $(0.02) $(0.02) $(0.08) $0.11
 Net income (loss) per share $(0.02) $(0.02) $(0.03) $0.13
 Weighted average shares
 outstanding 9,444,727 6,966,061 9,030,529 6,907,128
 -0- 3/4/93
 /CONTACT: Sigfred W. Peck, president and CEO of Allercare, 612-944-0551/
 (ALLR)


CO: Allercare, Inc. ST: Minnesota IN: MTC SU: ERN

AL -- MN012 -- 2976 03/04/93 12:15 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 4, 1993
Words:407
Previous Article:CASCADE MEDICAL NAMES CHIEF FINANCIAL OFFICER; MCFADDEN HELD SERIES OF POSITIONS AT CRAY RESEARCH
Next Article:BET HOLDINGS REPORTS SECOND QUARTER RESULTS; NET INCOME INCREASES 14 PERCENT ON REVENUE INCREASE OF 20 PERCENT
Topics:


Related Articles
ALLERCARE ANNOUNCES SECOND QUARTER RESULTS
ALLERCARE ANNOUNCES THIRD QUARTER RESULTS
ALLERCARE ANNOUNCES THIRD QUARTER RESULTS
ALLERCARE CONVERTS SUBORDINATED CONVERTIBLE DEBENTURES
ALLERCARE REPORTS RESULTS
ALLERCARE, INC. ANNOUNCES RESULTS
ALLERCARE ANNOUNCES RESULTS FOR FISCAL YEAR 1993
ALLERCARE, INC., ANNOUNCES RESULTS
ALLERCARE ANNOUNCES SALE OF LASALLE' '10' BUSINESS AND SECOND QUARTER RESULTS
NBTY Announces Record Third Quarter Results - Third Quarter Revenues Increase 73% - - Nine Month Revenues Up 78% -

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters